Hospital Maisonneuve-Rosemont
Montreal, Quebec H1T 2M4
4 studies enrolling now · 14 studies all time
What they study most
Acute Lymphoblastic Leukemia, Antimicrobial, Arthritis, Psoriatic, Bacteremia, Chronic Graft-versus-host Disease, Chronic Graft-versus-host-disease, Community-acquired Pneumonia, Influenza, COVID-19, Critically Ill, Endometrial Cancer, Endometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Studies at this site
- A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis — Recruiting now
- Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
- CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. — Recruiting now
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
- Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
- A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
- GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
- A Study in Adults With Untreated Acute Lymphoblastic Leukemia — Completed
- Study of Cemiplimab in Adults With Cervical Cancer — Completed
- Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed
- Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis — Completed
- Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
- Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed